![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhRT2qe4awCa03ZpP0ov6VBA2OwbyVH6nWIcEFX62H6wPSo8Vs3l5YaSBIGbvU-EIeV0vzE7oBqCPYQs3WgO981upknSZLk9wf55AkIihyrOAE8ZXHwBB-aZQE5Pp-kpQEKhk3xBF2Cpmab/s400/applegreen.gif)
It turns out this family has TNF Receptor-Associated Periodic Syndrome (TRAPS), also known as Hibernian Fever, which is due to mutations in the gene encoding for tumor necrosis factor receptor 1. The disease manifests as recurrent fevers and a chronic inflammatory state, similar to other hereditary periodic fever syndromes such as familial Mediterranean fever (FMF) or Muckle-Wells Syndrome, and the reason these individuals may get renal disease is due to AA amyloidosis. Patients with TRAPS can (logically enough) be treated with etanercept (Enbrel), a monoclonal antibody against TNF and prednisone. The patient described is being considered for a cadaveric renal transplant but has been warned that there is a strong possibility that amyloid deposition in her future allograft could occur.
No comments:
Post a Comment